Antibiotic prophylaxis for infective endocarditis. FDI Commission Working Group.
D000328:Adult; D000658:Amoxicillin / Q000008:administration & dosage / Q000627:therapeutic use; D000667:Ampicillin / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use; D016470:Bacteremia / Q000517:prevention & control; D002648:Child; D002981:Clindamycin / Q000008:administration & dosage / Q000627:therapeutic use; D017742:Dental Care for Chronically Ill; D004198:Disease Susceptibility; D004334:Drug Administration Schedule; D004697:Endocarditis, Bacterial / Q000517:prevention & control*; D015643:Erythromycin Ethylsuccinate / Q000008:administration & dosage / Q000627:therapeutic use; D005839:Gentamicins / Q000008:administration & dosage / Q000627:therapeutic use; D006331:Heart Diseases; D006801:Humans; D010349:Patient Compliance; D012307:Risk Factors; D014640:Vancomycin / Q000008:administration & dosage / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D005839:Gentamicins; D015643:Erythromycin Ethylsuccinate; D002981:Clindamycin; D014640:Vancomycin; D000667:Ampicillin; D000658:Amoxicillin